Itron (NASDAQ:ITRI) Price Target Raised to $125.00 at TD Cowen

Itron (NASDAQ:ITRI) had its price target raised by TD Cowen from $115.00 to $125.00 in a research report released on Friday, Marketbeat reports. They currently have a buy rating on the scientific and technical instruments company’s stock.

A number of other analysts also recently commented on the company. Stephens upped their price objective on Itron from $85.00 to $110.00 and gave the stock an equal weight rating in a report on Monday, May 6th. Oppenheimer upped their price objective on Itron from $110.00 to $112.00 and gave the stock an outperform rating in a report on Wednesday, July 17th. Canaccord Genuity Group upped their price objective on Itron from $115.00 to $120.00 and gave the stock a buy rating in a report on Thursday, June 20th. StockNews.com downgraded Itron from a strong-buy rating to a buy rating in a report on Friday, June 28th. Finally, JPMorgan Chase & Co. upped their price target on shares of Itron from $104.00 to $112.00 and gave the stock a neutral rating in a research report on Tuesday, July 16th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus price target of $114.00.

Itron Price Performance

Shares of NASDAQ:ITRI opened at $97.39 on Friday. The business’s 50 day simple moving average is $103.39 and its 200-day simple moving average is $94.38. The firm has a market capitalization of $4.47 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 0.91 and a beta of 1.45. The company has a debt-to-equity ratio of 0.98, a current ratio of 3.16 and a quick ratio of 1.40. Itron has a 12 month low of $56.11 and a 12 month high of $113.07.

Itron (NASDAQ:ITRI) last posted its earnings results on Thursday, August 1st. The scientific and technical instruments company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.25. Itron had a return on equity of 16.42% and a net margin of 7.98%. The firm had revenue of $609.07 million for the quarter, compared to analyst estimates of $599.25 million. During the same quarter in the prior year, the company earned $0.65 EPS. Itron’s revenue was up 12.6% on a year-over-year basis. As a group, equities analysts forecast that Itron will post 4.55 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Christopher E. Ware sold 311 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $106.84, for a total transaction of $33,227.24. Following the completion of the sale, the senior vice president now directly owns 15,371 shares of the company’s stock, valued at $1,642,237.64. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, CEO Thomas Deitrich sold 873 shares of the business’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $108.87, for a total transaction of $95,043.51. Following the completion of the transaction, the chief executive officer now owns 206,163 shares in the company, valued at $22,444,965.81. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Christopher E. Ware sold 311 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $106.84, for a total transaction of $33,227.24. Following the sale, the senior vice president now directly owns 15,371 shares of the company’s stock, valued at approximately $1,642,237.64. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,775 shares of company stock valued at $192,613. Insiders own 1.45% of the company’s stock.

Institutional Investors Weigh In On Itron

Several large investors have recently made changes to their positions in ITRI. Vanguard Group Inc. grew its position in Itron by 0.8% in the first quarter. Vanguard Group Inc. now owns 5,701,337 shares of the scientific and technical instruments company’s stock valued at $527,488,000 after purchasing an additional 45,909 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Itron by 3.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,681,573 shares of the scientific and technical instruments company’s stock valued at $126,978,000 after purchasing an additional 51,874 shares in the last quarter. Vontobel Holding Ltd. grew its position in Itron by 16.0% in the fourth quarter. Vontobel Holding Ltd. now owns 804,648 shares of the scientific and technical instruments company’s stock valued at $60,759,000 after purchasing an additional 110,849 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Itron by 2.2% in the first quarter. Janus Henderson Group PLC now owns 542,943 shares of the scientific and technical instruments company’s stock valued at $50,233,000 after acquiring an additional 11,918 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Itron by 3.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 518,157 shares of the scientific and technical instruments company’s stock valued at $39,126,000 after acquiring an additional 15,157 shares during the last quarter. Institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.